La Maison de la Rivière
- Research works
- 21 ▼ 100% vs 2013–17
- Citations
- 142 6.8 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 19% world 28%
Not ranked overall: La Maison de la Rivière is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at La Maison de la Rivière?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Prevention, Treatment, Public Health, Diagnosis, Cryptogenic Stroke, Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Jaundice.
- Pressure Ulcers
- Patent Foramen Ovale
- Neonatal Jaundice
- Glucose-6-Phosphate Dehydrogenase Deficiency
- Chemotherapy
- Quality of Life
- Public Health
- Prevention
- Epidemiology
- Treatment
- Diagnosis
- Cancer
- Cryptogenic Stroke
- Management
- Obesity
- Pathogen Transmission
- Risk Assessment
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Epidemiology3▲ 4.0×11 topics
- Prevention2▲ 24×3 topics
- Treatment2▲ 7.4×4 topics
- Public Health2▲ 5.9×4 topics
- Diagnosis1▲ 6.2×2 topics
- Quality of Life1▲ 4.2×2 topics
- Cancer1▲ 3.6×4 topics
- Chemotherapy1▲ 6.7×2 topics
- Cryptogenic Stroke1▲ 231×1 topic
- Glucose-6-Phosphate Dehydrogenase Deficiency1▲ 142×1 topic
- Management1▲ 6.2×2 topics
- Neonatal Jaundice1▲ 142×1 topic
- Obesity1▲ 6.3×2 topics
- Patent Foramen Ovale1▲ 231×1 topic
- Pathogen Transmission1▲ 74×2 topics
- Pressure Ulcers1▲ 295×1 topic
- Risk Assessment1▲ 8.1×1 topic
Which research topics does La Maison de la Rivière publish most on?
By volume in 2022–2025: Retinal Diseases and Treatments, Ocular Infections and Treatments, Ophthalmology and Visual Impairment Studies and Pharmacological Receptor Mechanisms and Effects.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Retinal Diseases and Treatments Ophthalmology 0 works
- 2 Ocular Infections and Treatments Ophthalmology 0 works
- 3 Ophthalmology and Visual Impairment Studies Epidemiology 0 works
- 4 Pharmacological Receptor Mechanisms and Effects Molecular Biology 0 works
- 5 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 6 Long-Term Effects of COVID-19 Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has La Maison de la Rivière's research output changed?
Output in 2018–2022 was 100% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.